Pappas Ventures logo

Pappas Ventures

North America, North Carolina, United States, Durham

Description

Pappas Ventures provides investment in the life sciences sector.

Investor Profile

Pappas Ventures has made 51 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Series A (25%)
  • Series B (25%)
  • Series C (16%)
  • Series Unknown (14%)
  • Series D (10%)
  • Series F (4%)
  • Private Equity (4%)
  • Post Ipo Equity (2%)

Country Focus

  • United States (90%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Biopharma
  • Medical
  • Health Diagnostics
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pappas Ventures frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 4
Pearl Street Venture Funds
North America, Indiana, United States, Indianapolis
Co-Investments: 4
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Domain Associates
North America, California, United States, San Diego
Co-Investments: 12
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 5
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 7
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 5
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 4
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
Asset Management Ventures (AMV)
North America, California, United States, Palo Alto
Co-Investments: 4

Which angels does Pappas Ventures often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Pappas Ventures?

VelosBio

San Diego, California, United States

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.

BiotechnologyHealth CareMedicalOncology
Series AOct 1, 2018
Amount Raised: $58,000,000
Kezar Life Sciences

South San Francisco, California, United States

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Health CareHealth DiagnosticsLife ScienceTherapeutics
Series BJul 25, 2017
Amount Raised: $50,000,000
Evidation Health

San Mateo, California, United States

We enable and empower everyone to participate in better health outcomes.

AnalyticsBig DataHealth CareMedicalMobile AppsSoftware
Series BOct 11, 2016
Amount Raised: $3,400,000
Rotation Medical

Plymouth, Minnesota, United States

Rotation Medical develops treatments for rotator cuff disease by reversing disease progression and restoring long-term shoulder function.

BiotechnologyHealth CareMedicalMedical Device
Series BAug 16, 2016
Amount Raised: $12,000,000
Milestone Pharmaceuticals

Montréal, Quebec, Canada

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

BiotechnologyHealth CareTherapeutics
Series BJun 15, 2015
Amount Raised: $17,000,000
Thrasos

Montréal, Quebec, Canada

Thrasos discovers and develops targeted therapies for the prevention and treatment of severe organ failures.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series DMar 31, 2015
Amount Raised: $21,000,000
Balance Therapeutics

San Bruno, California, United States

Balance Therapeutics is a R&D company focused on developing therapeutics to address conditions of intellectual disability.

Developer ToolsHealth CarePharmaceuticalTherapeutics
Series AMar 19, 2015
Amount Raised: $18,000,000
Aura Biosciences

Cambridge, Massachusetts, United States

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

BiotechnologyHealth CarePharmaceutical
Series BMar 5, 2015
Amount Raised: $21,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series CJan 13, 2015
Amount Raised: $37,100,000
Rotation Medical

Plymouth, Minnesota, United States

Rotation Medical develops treatments for rotator cuff disease by reversing disease progression and restoring long-term shoulder function.

BiotechnologyHealth CareMedicalMedical Device
Series BJul 2, 2014
Amount Raised: $27,200,000